Robert Weisman

Weisman covers the healthcare and life sciences industries for the Business section. He was a business reporter and editor for the Hartford Courant and the Seattle Times before joining the Globe in 2000.

Latest stories

Two Massachusetts biotechs soar in market rally

By , Globe Staff

Shares of Massachusetts biotechs Tetraphase Pharmaceuticals Inc. and Aveo Pharmaceuticals Inc. surged in Thursday trading, far outpacing the general stock market rally.

Could Big Pharma’s appetite for local biotechs hurt independents?

By , Globe Staff

Merck’s plan to buy Cubist Pharmaceuticals Inc. is just the latest example of Big Pharma expanding its local presence.

Vertex hires Broad Institute cofounder as research chief

By , Globe Staff

The Boston biotech company named David Altshuler, 50, as executive vice president for global research and chief scientific officer.

Boston Medical Center, Tufts in merger talks

By and , Globe Staff

A merger would link two nonprofit hospitals that both treat many low-income patients and have endured financial struggles.